Home / Posts Tagged "Indian pharma"

The Indian pharmaceutical sector is strategically poised to capitalize on the recent healthcare initiatives introduced by President Donald Trump, aimed at enhancing the affordability and accessibility of medical treatments in the United States. This development presents significant opportunities for Indian drug manufacturers to expand their

READ MORE

Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes Firms deploying GenAI are seeing reduction in early-stage drug development costs, and improvement in operational efficiencies   EY Parthenon (EY-P), the leading strategy consulting firm, in partnership with BioAsia,

READ MORE

With an aim to create awareness and build the capabilities of the Indian pharma sector to adopt global best manufacturing practices, the Indian Pharmaceutical Alliance (IPA) is organizing the 7th Advanced Good Manufacturing Practices Workshop. The workshops will be conducted across three locations – Ahmedabad

READ MORE